Perkins Coie group experts on region’s biotech

Perkins Coie LLP

www.perkinscoie.com

Perkins Coie is proud to have a comprehensive biotechnology and life sciences practice serving the Rocky Mountain region.

SPONSORED CONTENT

Prioritizing mental health in hospice care

Prioritizing mental health support alongside physical comfort, Pathways hospice care aims to enhance the quality of life for patients and their families during one of life's most challenging transitions.

Our Denver-based attorneys have extensive experience in providing assistance to local and national biotechnology and life sciences companies.

With more than 40 combined years of practicing law in Colorado, our attorneys know the local market, and are very familiar with the issues facing biotechnology and life science companies.

Local knowledge backed by national resources is why biotechnology firms turn first to Perkins Coie for the answers to their pressing legal needs in connection with both debt and equity financing, tax advice, corporate structuring and environmental matters.

We represent a wide variety of biotechnology and life sciences companies, including a number of publicly traded companies: ICOS Corp., Immunex Corp., NeoRx Corp., Neopath Inc., Ostex International Inc., ProCyte Corp., QLT Photo Therapeutics Inc (TSE/NASDAQ), Targeted Genetics Corp. and Alcide Corp.

In addition, we have represented Darwin Molecular Corp., a privately held company acquired by Chiroscience Group plc, a public UK company, and Genetic Systems Corp., a public company acquired by Bristol-Myers Squibb and subsequently transferred to Sanofi Winthrop.

On behalf of our biotechnology clients, we have negotiated ventures and contracts with such companies as Abbott Laboratories, Glaxo, Bristol-Myers Squibb, Eli Lilly and Co., DuPont Merck, Schering-Plough, Johnson & Johnson, Syntex, Hybritech, Amgen, AstraZeneca, Beckman Instruments, Bayer AG, Hoffmann-La Roche, Boehringer Ingelheim, Rhone-Poulenc Rorer, Schwarz Pharma, Pharmacia Biotech, Sanofi Winthrop and Suntory.

In providing a broad range of legal and general counsel services to biotechnology clients, Perkins Coie has been involved with a wide spectrum of issues that arise in the course of starting, operating and buying or selling a biotechnology company. These include funding and securities offerings, licensing and corporate partnering, protecting trade secret and inventor rights, as well as reorganizations, recapitalizations and structuring tax-efficient acquisitions and dispositions.